首页> 外文期刊>ChemMedChem >Synthesis and Evaluation of Anticancer Natural Product Analogues Based on Angelmarin: Targeting the Tolerance towards Nutrient Deprivation
【24h】

Synthesis and Evaluation of Anticancer Natural Product Analogues Based on Angelmarin: Targeting the Tolerance towards Nutrient Deprivation

机译:基于Angelmarin的抗癌天然产物类似物的合成和评估:针对营养剥夺的耐受性

获取原文
获取原文并翻译 | 示例
           

摘要

Rapidly growing solid tumours are often inherently hypovascu-lar, thus exhibiting reduced oxygen and nutrient supply. This has been well documented in pancreatic tumours. Rather than impeding cancer progression, such poor metabolic conditions can contribute to genomic instability, impaired cellular repair, mutagenesis, and resistance to chemotherapy, thus worsening prognoses for patients.The therapeutic strategies of angiogenesis inhibition and vascular targeting endeavour to kill tumour cells by selectively depriving them of oxygen and nutrients. In this light, aggressive tumours that thrive despite being chronically hypoxic and nutrient-deprived present a serious therapeutic challenge. Despite considerable evidence of angiogenesis, many pancreatic tumours remain hypovascular, hypoxic, and starved of nutrients while continuing to grow rapidly.
机译:快速生长的实体瘤通常固有地血管减少,因此表现出减少的氧气和营养供应。这已经在胰腺肿瘤中有据可查。这种不良的代谢状况不仅不会阻碍癌症的进展,反而会导致基因组不稳定,受损的细胞修复,诱变和对化学疗法的抵抗力,从而使患者的预后恶化。血管生成抑制和血管靶向的治疗策略旨在通过选择性剥夺肿瘤细胞来杀死肿瘤他们的氧气和营养。鉴于此,尽管长期缺氧和营养缺乏,但仍会壮成长的侵袭性肿瘤提出了严重的治疗挑战。尽管有大量的血管生成证据,但许多胰腺肿瘤仍保持低血管,低氧和营养缺乏,同时继续快速生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号